A single-vial combination of Semaglutide and Methylcobalamin B12, compounded for clinics running weekly GLP-1 injection protocols. Direct pricing, 24-72 hour shipping, 42 licensed states.
This formulation combines the GLP-1 receptor agonist Semaglutide with Methylcobalamin B12 in one injectable vial. B12 supplementation is commonly used alongside GLP-1 therapy because patients on caloric restriction may experience reduced nutrient absorption. The single-vial design eliminates the need for a separate B12 injection, which simplifies the patient experience and reduces clinic inventory.
Clinics prescribing weekly Semaglutide injections often pair them with B12 supplementation. The combination vial streamlines this into one injection per visit or per self-administration event. This is particularly popular with telehealth weight loss programs where patient convenience directly impacts adherence and retention.
One Injection Instead of Two. Patients get GLP-1 therapy and B12 support in a single vial. Higher compliance, lower dropout.Built for High-Volume Clinics. Ordered across hundreds of active clinics. Consistent stock and fast reorder processing.Direct Pharmacy Pricing. No middleman fees on any formulation.
Patients on GLP-1 therapy often reduce caloric intake, which can lower B12 absorption. The combination supports metabolic function during weight management protocols.
Yes. Promise compounds both standalone Semaglutide and the Semaglutide + B12 combination. Order whichever your protocol calls for.
A single access point for a wide range of 503A formulary products, catering to the requirements of any medical clinic, med spa, or telehealth provider.
At Promise Pharmacy, our dedicated team of hormone health specialists is led by Amy Patel, a seasoned expert in sterile compounding with more than 25 years of experience.
